-- Shanghai Allist Pharmaceuticals' (SHA:688578) attributable profit rose 55% to 632.8 million yuan in the first quarter from 395.8 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.
Earnings per share at the drug manufacturer increased to 1.41 yuan from 0.91 yuan in the prior-year period.
Operating income grew 44% year over year to 1.58 billion yuan from 1.10 billion yuan.